Meeting
2022 ASCO Annual Meeting
Factors associated with the occurrence of myocardial infarction in patients treated for melanoma.
Authors
Xianying Pan
Department of Pharmacoepidemiology, Bristol Myers Squibb, Princeton, NJ
Xianying Pan , Devashish Verma , Jiayin Zhang , Yifan Zhang , Xiaomei Ma
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Etiology/Epidemiology
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10562)
DOI
10.1200/JCO.2022.40.16_suppl.10562
Abstract #
10562
Poster Bd #
438
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Treatment at twilight: Is less more in the management of octogenarians with non-small cell lung cancer (NSCLC)?
First Author: Ethan Burns
Poster
2022 ASCO Annual Meeting
Predictors of response to immune checkpoint inhibitors (ICI) rechallenge post-disease progression in solid tumors: A systematic review and meta-analyses.
First Author: Hassan Mohammed Abushukair
Poster
2020 ASCO Virtual Scientific Program
Surgery for unresectable stage IIIC and IV melanoma in the era of new systemic therapy.
First Author: Stephanie Blankenstein
Poster
2014 ASCO Annual Meeting
Predictors of overall survival in patients diagnosed with desmoplastic small round cell tumor (DSRCT).
First Author: Alexander Noor Shoushtari